谷歌浏览器插件

订阅小程序

在清言上使用

立即登录

学术主页个人账号

我的关注论文收藏浏览历史

Sustained Improvements over 140 Weeks in Signs, Symptoms, and Quality of Life with Upadacitinib in Adolescents and Adults with Moderate-to-severe Atopic Dermatitis: Integrated Results from the Phase 3 Measure Up 1 and Measure Up 2 Studies

Vimal H. Prajapati,Christopher G. Bunick,Kilian Eyerich,Linda Stein Gold, Fabrizio Galimberti,Brian Calimlim,Henrique Teixeira,Xiaofei Hu, Yang,Cristina Sancho,Ayman Grada,Alan D. Irvine

BRITISH JOURNAL OF DERMATOLOGY（2024）

引用 0|浏览4

暂无评分

关键词

atopic dermatitis,moderate-to-severe,patient-reported outcomes,upadacitinib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要